talactoferrin alfa has been researched along with Colonic Neoplasms in 1 studies
talactoferrin alfa: recombinant human lactoferrin, an oral drug for treatment of refractory solid tumors; in Phase I trial 5/2006
Colonic Neoplasms: Tumors or cancer of the COLON.
Excerpt | Relevance | Reference |
---|---|---|
" Talactoferrin alfa (TLf) is a recombinant human Lf shown to protect against sepsis and necrotizing enterocolitis as well as cancer." | 3.80 | Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk. ( Du, X; Jiang, R; Lönnerdal, B, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, R | 1 |
Du, X | 1 |
Lönnerdal, B | 1 |
1 other study available for talactoferrin alfa and Colonic Neoplasms
Article | Year |
---|---|
Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk.
Topics: Animals; Apoptosis; Caco-2 Cells; Cattle; Cell Proliferation; Chemokine CCL20; Colonic Neoplasms; En | 2014 |